Delivery Order SPE2DB20D3505-SPE2DB22FT7H3
- Not listed
- This federal contract award is for the delivery of 4,563,284,097 units of Zolmitriptan 5 mg nasal spray to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $1,615.41, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 9, 2024. The contract has an ultimate completion date of January 10, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of Zolmitriptan 5 mg nasal spray to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $13,760.98 and an ultimate completion date of December 26, 2023. The contract was awarded on December 22, 2023 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a...
- This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Zolmitriptan 5 mg nasal spray. The contract has a ceiling value of $5,884.97 and a completion date of July 24, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award is for the delivery of Zolmitriptan 5 mg nasal spray to the Defense Logistics Agency (DLA), a defense agency. The $2,042.23 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- This federal contract award, valued at $1,504.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of Zolmitriptan 2.5 mg nasal spray in packages of 6, with a completion date of February 17, 2023. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $14,720.75 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of 4564042929 ZOLMITRIPTAN 5 MG NASAL SPRAY 6S, a pharmaceutical product, with a period of performance through March 22, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA, which serves...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $5,009.93 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of Zolmitriptan 5 mg nasal spray, with a performance period through March 28, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB24FFK02) valued at $7,151.56 for the supply of Zolmitriptan 5 mg nasal spray. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 1, 2024. The contract is a firm fixed-price, indefinite delivery/indefinite quantity (IDIQ) vehicle that allows the DLA to efficiently procure a wide range of pharmaceutical products...
- This federal contract award is for the delivery of Zolmitriptan 5 mg Nasal Spray in quantities of 6 per package to the Defense Logistics Agency (DLA). The contract, valued at $6,486.22, was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price, and the ultimate completion date is June 5, 2024. This contract award is not associated with a set-aside designation....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,612.21 firm-fixed-price delivery order is for the supply of Zolmitriptan 5 mg nasal spray, a medication used to treat migraine headaches. The contract has an ultimate completion date of August 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB22FT7H3Delivery Order
This federal contract award is for the delivery of Zolmitriptan 5 mg nasal spray to the Defense Logistics Agency (DLA). The $1,813.73 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 28, 2022. The contract has an ultimate completion date of April 29, 2022 and was not set aside for any specific business type. AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical care items, to support military healthcare programs globally. Additionally, AmerisourceBergen maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 4/28/22 |